At a glance
ClinicalIndex Comparison Record- ✓Diagnosis of mild-to-moderate asthma
- ✕Medical history of a lung disorder other than asthma
- ✕Recent upper respiratory tract infection
- ✕Not in good, stable health (other than asthma)
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Double-Blind, Randomized, Placebo-Controlled, Multicenter, 2-Period, Crossover Study to Evaluate the Effects of a Single Dose of Montelukast on Exercise-Induced Bronchospasm
In Brief
A Phase 3 clinical trial evaluating Comparator: Montelukast and Comparator: Placebo for Asthma, Exercise-Induced. Completed, enrolled 62 participants.
Detailed Summary
The purpose of this study is to determine the effect of an approved medication being studied in support of a new approach in the prevention of exercise-induced asthma (a worsening of asthma caused by exercise, also known as exercise-induced bronchospasm), in patients who have a history of worsening asthma after exercise.
Study Details
Timeline
Interventions
Montelukast 10 mg tablet administered orally as a single witnessed dose before exercise challenge
Placebo tablet administered orally as a single witnessed dose before exercise challenge